CLEC12A and acute myeloid leukemia: CD133 (Reuvekamp et al., 2025a) CD32 (Ho et al., 2016), CLL-1 (Larsen et al., 2012), CD244 (Quek et al., 2014) have been explored in CD34− AML, either individually or in combination with CD38 (Ho et al., 2016).